ZZ Biotech
PrivateLast Round
Grant
May 24, 2022
Total Funding Raised
$18.5M
Company Overview
ZZ Biotech operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in July 2016.
ZZ Biotech is a biotechnology company that develops biological treatments for ischemic stroke, amyotrophic lateral sclerosis (ALS), and other neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZZ Biotech Comparables
Compare ZZ Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck | 85% | |
| NoNO Inc. | 83% | |
| Argenica Therapeutics | 79% |
For institutional investors. Book with your work email.
ZZ Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 24, 2022 | ||||
| Grant | Jul 5, 2016 | ||||
| Grant | Dec 1, 2015 | ||||
| Grant | Apr 22, 2014 | ||||
| VC Round | Apr 22, 2014 | ||||
Private Equity | Oct 2, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ZZ Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biopharmaceuticals Australia | Grant |
| NIH RADx | VC Round, Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| Broadview Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 342% MoM, reaching 1.5K.
- Mar 12, 2025
Grew 133% QoQ, from 6 to 14 employees.
For institutional investors. Book with your work email.
ZZ Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ZZ Biotech's valuation, stock price, and market status.
Is ZZ Biotech a public or private company?
ZZ Biotech is a private company.
What is the current stock price of ZZ Biotech?
ZZ Biotech is a private company, so its shares have no public market price. Caplight tracks ZZ Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ZZ Biotech worth (valuation)?
Valuation information for ZZ Biotech is not publicly available.
Can I buy ZZ Biotech stock?
ZZ Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ZZ Biotech's last funding round?
ZZ Biotech's most recent funding round was Grant on May 24, 2022.
Who are the main investors in ZZ Biotech?
Key investors in ZZ Biotech include Biopharmaceuticals Australia, National Institute of Neurological Disorders and Stroke, Broadview Ventures.
Will ZZ Biotech IPO soon?
No public IPO plans have been announced for ZZ Biotech.
How can I track ZZ Biotech secondary market activity?
Caplight tracks bids, offers, and trades in ZZ Biotech's shares on secondary markets.